EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MUC1 as a Survival Effector of Radiotherapy‐Induced Epithelial Hybrid States in Basal‐Like Breast Cancer

Garyfallia Pantelaiou-Prokaki iD, Husam Bamahmoud, Nadine S Georges, Shaishavi Jansari, Annika Jung, Daniela Grimm, Evangelos Prokakis, Fabian Alexander Gayer, Maryam Deldar, Christian Dullin, Julia Gallwas, Florian Wegwitz iD und 1 weitere

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Garyfallia Pantelaiou-Prokaki und 12 weiteren Autor:innen. Beteiligte Einrichtung: Translational Molecular Imaging, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. Hauptthemen laut MEDLINE: Mucin-1, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Basal‐like breast cancer (BLBC) is characterized as the most aggressive and poorly understood breast cancer (BC) subtype. Next to surgery, conventional chemotherapy and immunotherapy, radiotherapy (RT) represents one of the primary treatment options. Transcriptional plasticity is largely responsible for BLBC's ability to rapidly adapt to genotoxic stress, enabling cell survival, tumor repopulation, and disease progression. Our research group has recently shown that chemotherapy primarily elicits the epithelial‐to‐mesenchymal transition (EMT) transcriptomic program by epigenetically derepressing the expression of several important EMT‐promoting factors, which are crucial for drug tolerance and disease relapse. However, the induced transcriptomic programs upon RT in BLBC have been elusively addressed. To fill this gap, we leveraged high‐throughput bulk and spatial transcriptomic data in a syngeneic mouse model of BLBC, corroborated by publicly available patient‐derived bulk transcriptomic data and combined with an in vitro 3D BLBC model approach. Contrary to our expectations, we found that irradiated basal‐like breast cancer (BLBC) tumors shifted their epithelial/mesenchymal hybrid state toward a stronger epithelial gene expression program, ultimately driving MUC1 (Mucin 1) expression as a key mediator of cell survival following RT. Altogether, our study uncovers a new aspect of the BLBC transcriptional plasticity elicited by RT, leading to a distinct hybrid phenotypic state from that upon chemotherapy. Concluding, these data underscore the potential clinical value of MUC1 as a therapeutic target or prognostic marker to optimize BLBC patients’ response to RT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucin-1Breast NeoplasmsAnimalsFemaleMiceHumansEpithelial-Mesenchymal TransitionCell Line, TumorGene Expression Regulation, NeoplasticTranscriptomeCell Survival

Stichwörter der Autor:innen

MUC1basal‐like breast cancerepithelial/mesenchymal hybrid stateirradiationsyngeneic mouse model

Substanzen

Mucin-1MUC1 protein, humanmuc1 protein, mouse

Autor:innen und Institutionen

  • Translational Molecular Imaging, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Department of Gynecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany.
  • Department of Urology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Department of Urology, University Medical Centre Göttingen, Göttingen, Germany.
  • Institute for Diagnostic and Interventional Radiology, University Medical Center Göttingen, Göttingen, Germany.
  • Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.

ORCID-Profile: Garyfallia Pantelaiou-Prokaki, Florian Wegwitz, Frauke Alves

Zitieren

APA

Pantelaiou-Prokaki, G., Bamahmoud, H., Georges, N. S., Jansari, S., Jung, A., Grimm, D., Prokakis, E., Gayer, F. A., Deldar, M., Dullin, C., Gallwas, J., Wegwitz, F., & Alves, F. (2026). MUC1 as a Survival Effector of Radiotherapy‐Induced Epithelial Hybrid States in Basal‐Like Breast Cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.70487

Vancouver

Pantelaiou-Prokaki G, Bamahmoud H, Georges NS, Jansari S, Jung A, Grimm D, et al. MUC1 as a Survival Effector of Radiotherapy‐Induced Epithelial Hybrid States in Basal‐Like Breast Cancer. International Journal of Cancer. 2026. doi:10.1002/ijc.70487

BibTeX
@article{PantelaiouProkaki2026,
  author = {Pantelaiou-Prokaki, Garyfallia and Bamahmoud, Husam and Georges, Nadine S and Jansari, Shaishavi and Jung, Annika and Grimm, Daniela and Prokakis, Evangelos and Gayer, Fabian Alexander and Deldar, Maryam and Dullin, Christian and Gallwas, Julia and Wegwitz, Florian and Alves, Frauke},
  title = {MUC1 as a Survival Effector of Radiotherapy‐Induced Epithelial Hybrid States in Basal‐Like Breast Cancer},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70487}
}
Kostenlos starten →